Nanotherapeutics to overcome conventional cancer chemotherapy limitations.

K. Kathiresan,M. Chidambaram,R. Manavalan

DOI: https://doi.org/10.18433/J30C7D

2011-02-16

Journal of Pharmacy & Pharmaceutical Sciences

Abstract:Cancer is one of the major causes of death worldwide and chemotherapy is a major therapeutic approach for the treatment which may be used alone or combined with other forms of therapy. However, conventional chemotherapy suffers lack of aqueous solubility, lack of selectivity and multidrug resistance. Nanotherapeutics is rapidly progressing aimed to solve several limitations of conventional drug delivery systems. Nonspecific target of cancer chemotherapy leads to damage rapidly proliferating normal cells and can be significantly reduced through folate and transferrin mediated nanotherapeutics which are aimed to target cancerous cells. Multidrug resistance is challenge in cancer chemotherapy which can be significantly reversed by solid lipid nanoparticles, polymeric nanoparticles, mesoporous silica nanoparticles, nanoparticulated chemosensitizer, nanoparticluated poloxamer and magnetic nanoparticles. Hydrophobic nature of chemotherapeutics leads to poor aqueous solubility and low bioavailability which can be overcome by nanocrystals, albumin based nanoparticles, liposomal formulation, polymeric micelles, cyclodextrin and chitosan based nanoparticles. This review focuses the role of nanotherapeutics to overcome lack of selectivity, multidrug resistance and lack of aqueous solubility of conventional cancer chemotherapy.

Medicine,Chemistry,Materials Science

What problem does this paper attempt to address?

The paper primarily explores the role of nanotherapy technology in overcoming the limitations of traditional cancer chemotherapy. Specifically, the paper attempts to address the following three main issues:

1. **Lack of Selectivity**: Traditional chemotherapy drugs often lack selectivity for cancer cells, leading to significant damage to normal rapidly proliferating cells. By using targeted nanoparticles (such as folate-mediated or transferrin-mediated nanoparticles), this nonspecific damage can be significantly reduced.

2. **Multidrug Resistance (MDR)**: Multidrug resistance is a major challenge in cancer chemotherapy, mainly due to efflux pumps on the tumor cell membrane (such as P-glycoprotein) that expel various anticancer drugs out of the cells. By using various nanoparticles (such as solid lipid nanoparticles, polymer nanoparticles, mesoporous silica nanoparticles, etc.), multidrug resistance can be reversed, enhancing the efficacy of the drugs.

3. **Poor Water Solubility**: Many chemotherapy drugs lack good water solubility due to their hydrophobic nature, resulting in low bioavailability. By using technologies such as nanocrystals, albumin-based nanoparticles, liposomal formulations, polymer micelles, cyclodextrins, and chitosan-based nanoparticles, the water solubility and bioavailability of these drugs can be significantly improved.

In summary, this paper highlights how nanotherapy technology can overcome the limitations of traditional cancer chemotherapy by improving drug selectivity, reversing multidrug resistance, and enhancing water solubility.